Cargando…
Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study
Two COVID-19 outbreaks occurred in Henan province in early 2022—one was a Delta variant outbreak and the other was an Omicron variant outbreak. COVID-19 vaccines used at the time of the outbreak were inactivated, 91.8%; protein subunit, 7.5%; and adenovirus5-vectored, 0.7% vaccines. The outbreaks pr...
Autores principales: | Tang, Lin, Zhang, Yanyang, Wang, Fuzhen, Wu, Dan, Qian, Zhao-Hui, Zhang, Rui, Wang, Ai-Bin, Huang, Chang, Wang, Haifeng, Ye, Ying, Lu, Mingxia, Wang, Changshuang, Ma, Ya-Ting, Pan, Jingjing, Li, Ya-fei, Lv, Xiao-Ya, An, Zhijie, Rodewald, Lance, Wang, Xuan-Yi, Shao, Yi-Ming, Wu, Zhi-Yin, Yin, Zundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659710/ https://www.ncbi.nlm.nih.gov/pubmed/36368753 http://dx.doi.org/10.1136/bmjopen-2022-063919 |
Ejemplares similares
-
Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021) -
Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021) -
Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021
por: Wu, Dan, et al.
Publicado: (2022) -
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022) -
“If the world doesn’t share the vaccine, the virus will take on the world”
por: Yin, Zundong, et al.
Publicado: (2021)